Female Sexual Dysfunction
Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
Published in Gene Therapy Weekly, October 4th, 2007
Intra-Cellular Therapies announced it has developed a novel series of non-hormonal compounds that show promise in the treatment of female sexual dysfunction (FSD). These small molecule agents are specific and potent inhibitors designed to regulate neuronal activity in selected regions of the brain. The Company believes these compounds may have utility in the treatment of hypoactive sexual desire disorder (HSDD), a condition that affects a significant percentage of older, peri- and post-menopausal women and is one of the disorders commonly classified as "female sexual dysfunction."
ITI's molecules have demonstrated promising activity in animal models of sexual behavior,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-10-04)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Novel Program Underway to Increase Participation in Clinical Trials - Cancer Gene Therapy
T vs. B: Re-engineered Human T Cells Effectively Target and Kill Cancerous B Cells - Gaucher Disease
Study Examines Implications of Genetic Screening for Certain Disease That Can Be Less Serious, Treatable - Gene Therapy
Mechanism for the in-vivo transport of siRNA - Mathematical Modeling
Scientists synthesize memory in yeast cells - Biopharmaceuticals
AVI BioPharma Receives Department of Defense Contract for NEUGENE Program in Dengue Virus - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
